The global radiofrequency ablation devices (RFAD) market has witnessed an unprecedented growth in the past few years. The rise in the incidence of patients with chronic pain due to the increase in the prevalence of obesity, diabetes, osteoarthritis, cancer, and rheumatoid arthritis have contributed towards the market growth.
Portland, OR -- (SBWIRE) -- 09/28/2017 -- The Radiofrequency Ablation Devices Market growth is favored by the increase in prevalence of cardiovascular diseases, such as, atrial fibrillation, incidence of patients' suffering from cancer and pain, and increase in demand for minimally-invasive procedures. Radiofrequency Ablation Devices Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $3,785 million by 2022, registering a CAGR of 11.8% during the period 2016-2022. The disposable devices segment dominated the market in 2015 and is expected to lead throughout analysis period.
The report includes revenue generated from the sales of ablation devices that use radiofrequency energy for the process of ablation. Sales from the ablation devices that use other energy sources are not included in this report. The report does not include revenue generated from the service provided by doctors, nurses & consultancy, and hospital stay charges during the ablation treatment.
The report analyzes the radiofrequency ablation (RFA) devices market based on three categories: application, product type, and geography. Based on application, it is segmented into cardiology, oncology, and pain management. Based on product type, it is divided into devices and disposables. Based on geography, the market is analyzed as North America, Europe, Asia-Pacific, and LAMEA.
Based on application, the RFA devices market can be categorized into cardiology, oncology and pain management. There are two types of ablation catheters viz. conventional and irrigated-tip RFA catheters that can be used for the cardiology segment. The oncology segment is further segmented into spinal metastases, breast, colorectal, lung, prostate, liver, and kidney cancer. The pain management segment is further divided into neck, shoulder, upper back, lower back, knee pain, and other pain syndromes.
Based on product type, the RFA devices market can be segmented into devices and disposables. The device segment consists of RF generator, which is the main component of the RFA device. It generates electric current in the range of radiofrequency waves, and this current is transmitted through the insulated needle to deactivate the nerve and block the pain signal. The generator is connected to the needle electrodes and grounding pads by insulated wires. It uses an unmodified sinusoid that ranges in the frequency of 500 kHz to 6 GHz. The disposables used during radiofrequency ablation procedure include RF cannula, RF needles, RF single-use catheters, RF single-use probes, RF single-use electrodes, RF probes, and RF electrodes.
Key Findings of the Radiofrequency Ablation Devices Market
- Cardiology was the leading segment in 2015, and is expected to maintain the lead throughout the analysis period.
- Disposables dominated the market with over two-thirds of the total market share in 2015.
- Radiofrequency ablation devices used for oncology is estimated to be the fastest growing segments.
- Radiofrequency ablation devices market in Russia is projected to grow at a high CAGR of 14.3% and would reach $23 million by 2022.
- Asia-Pacific market for radiofrequency ablation devices will be the fastest growing regional market.
Limited Period Offer! Get 30% discount on this report
Click to get Sample!